We performed serum
metabolome analysis of di(2-ethylhexyl)phthalate
(DEHP)-exposed and control pregnant mice. Pregnant mice (
n
= 5) were fed a DEHP-containing diet (0.1% or 0.2% DEHP) or a normal
diet (control) from gestational days 0–18. After maternal exposure
to 0.2% DEHP there were no surviving fetuses, indicating its strong
fetal lethality. There were no significant differences in the numbers
of fetuses and placentas between the 0.1% DEHP and control groups,
although fetal viability differed significantly between them, suggesting
that maternal exposure to 0.1% DEHP could inhibit fetal growth. Metabolomics
successfully detected 169 metabolites in serum. Principal component
analysis (PCA) demonstrated that the three groups were clearly separated
on PCA score plots. The biological interpretation of PC1 was fetal
lethality, whereas PC2 meant metabolic alteration of pregnant mice
via DEHP exposure without fetal lethality. In particular, the first
component was significantly correlated with fetal viability, demonstrating
that maternal metabolome changes via DEHP exposure were strongly related
to fetal lethality. Levels of some amino acids were significantly
increased in the DEHP-exposed groups, whereas those of some fatty
acids, nicotinic acid, and 1,5-anhydroglucitol were significantly
decreased in the DEHP groups. DEHP-induced increases in glycine levels
could cause fetal neurological disorders, and decreases in nicotinic
acid could inhibit fetal growth. In addition, a machine-learning Random
forest could determine 16 potential biomarkers of DEHP exposure, and
data-driven network analysis revealed that nicotinic acid was the
most influential hub metabolite in the metabolic network. These findings
will be useful for understanding the effects of DEHP on the maternal
metabolome in pregnancy and their relationship to fetal lethality.